Zivo logo.jpg
ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021
June 02, 2021 09:30 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (NASDAQ:ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic,...
Zivo logo.jpg
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
June 02, 2021 09:05 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., June 02, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW) (“ZIVO” and the “Company”), a biotech/agtech R&D company engaged in the development and...
Zivo logo.jpg
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
May 27, 2021 20:42 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., May 27, 2021 (GLOBE NEWSWIRE) -- Zivo Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of...
Zivo logo.jpg
ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health
April 26, 2021 12:06 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the development and commercialization of...
Zivo logo.jpg
ZIVO Bioscience to Participate in Maxim Group’s Inaugural Emerging Growth Virtual Conference
March 11, 2021 12:25 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., March 11, 2021 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech/agtech R&D company engaged in the development and commercialization of therapeutic and...
Largest Shareholder of ZIVO Bioscience, Inc. to extend maturity date of its Convertible Debt
February 12, 2018 18:09 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Feb. 12, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products...
ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
February 01, 2018 07:52 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products...
ZIVO Bioscience Subsidiary Wellmetris Selected to Present at Biotech Showcase During JPMorgan Healthcare Conference Jan 7-10 in San Francisco, CA
January 08, 2018 08:00 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Jan. 08, 2018 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO), a biotech/agtech R&D company, announced today that its WellMetris subsidiary will be presenting at...
ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for November 8, 2017 in Detroit, Michigan
November 07, 2017 08:17 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Nov. 07, 2017 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc., (OTCQB:ZIVO) a Michigan-based biotech firm, invites shareholders, analysts and partners to its annual shareholder...
ZIVO Bioscience and NutriQuest LLC Conclude Two Poultry Studies With Positive Results, Continue to Move Forward With FDA Compliance
September 19, 2017 09:42 ET | Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Sept. 19, 2017 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products...